Observation versus radiotherapy with or without temozolomide in postoperative WHO grade II high-risk low-grade glioma: a retrospective cohort studyJingjing Wang, Xingchen Peng, Yan He et al.|Neurosurgical Review|2020Cited by 24
Inhibition of Mitochondrial Carrier Homolog 2 (MTCH2) Suppresses Tumor Invasion and Enhances Sensitivity to Temozolomide in Malignant GliomaQiuyun Yuan, Yan‐Hui Liu|Research Square|2020Cited by 2
Inhibition of Mitochondrial Carrier Homolog 2 (MTCH2) Suppresses Tumor Invasion and Enhances Sensitivity to Temozolomide in Malignant GliomaQiuyun Yuan, Yan‐Hui Liu|Research Square|2020Cited by 0